Based on the MedMira Inc stock forecast from 0 analysts, the average analyst target price for MedMira Inc is not available over the next 12 months. MedMira Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of MedMira Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, MedMira Inc’s stock price was EUR 0.05. MedMira Inc’s stock price has changed by +0.00% over the past week, +13.64% over the past month and -14.53% over the last year.
No recent analyst target price found for MedMira Inc
No recent average analyst rating found for MedMira Inc
Company Overview MedMira Inc
MedMira Inc. is a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and the Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit for rapid diagnostics development and Reveal G4 HIV tests. Additionally, the company offers the VYRATM TriDemic antigen rapid test, which distinguishes between three respiratory viruses. The company distributes its products through a network of medical distributors and strategic business development partners, serving customers in various healthcare sectors, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG. Read Less
MedMira Inc. is a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and H...Read More
Frequently Asked Questions About MedMira Inc (47M:F) Stock
Stock Target Advisor's fundamental analysis for MedMira Inc's stock is Very Bearish.
Unfortunately we do not have enough data on 47M:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 47M:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 47M:F's stock to indicate if its overvalued.
The last closing price of 47M:F's stock was EUR 0.05.
The most recent market capitalization for 47M:F is EUR 0.04B.
Unfortunately we do not have enough analyst data on 47M:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains MedMira Inc's stock.
As per our most recent records MedMira Inc has 0 Employees.
MedMira Inc's registered address is 155 Chain Lake Drive, Halifax, NS, Canada, B3S 1B3.
You can get more information about it from MedMira Inc's website at https://www.medmira.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About MedMira Inc (47M:F) Stock
Stock Target Advisor's fundamental analysis for MedMira Inc's stock is Very Bearish.
Unfortunately we do not have enough data on 47M:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 47M:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 47M:F's stock to indicate if its overvalued.
The last closing price of 47M:F's stock was EUR 0.05.
The most recent market capitalization for 47M:F is EUR 0.04B.
Unfortunately we do not have enough analyst data on 47M:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains MedMira Inc's stock.
As per our most recent records MedMira Inc has 0 Employees.
MedMira Inc's registered address is 155 Chain Lake Drive, Halifax, NS, Canada, B3S 1B3.
You can get more information about it from MedMira Inc's website at https://www.medmira.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 47M:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
